JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sjögreen, K.
Right arrow Articles by Strand, S.-E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sjögreen, K.
Right arrow Articles by Strand, S.-E.
Journal of Nuclear Medicine Vol. 43 No. 7 972-982
© 2002 by Society of Nuclear Medicine


Basic Science Investigations

An Activity Quantification Method Based on Registration of CT and Whole-Body Scintillation Camera Images, with Application to 131I

Katarina Sjögreen, PhD, Michael Ljungberg, PhD and Sven-Erik Strand, PhD

Department of Radiation Physics, Jubileum Institute, University Hospital, Lund University, Lund, Sweden

This article presents a new method for conjugate view activity quantification for 131I-labeled monoclonal antibody distribution. Methods: The method is based on the combined use of images from 3 modalities: whole-body (WB) scintillation camera scanning, WB transmission scanning using 57Co, and CT. All images are coaligned using a recently developed program for the registration of WB images. Corrections for attenuation, scatter, and septal penetration are performed in image space. Compensation for scatter and septal penetration is performed by deconvolution, using point-response functions determined from Monte Carlo simulations. Attenuation correction is performed by applying a patient-specific 364-keV narrow-beam attenuation map obtained by combining information from the CT and the transmission scan. A relationship is presented for the conversion of the CT numbers to mass density. The attenuation- and scatter-compensated image is converted from counts to activity using a sensitivity value that was determined for 364-keV photons in air. This activity projection image is then analyzed for the activity of volumes of interest (VOI) using 2-dimensional regions of interest (ROIs) that are determined from the CT study. The CT is first resliced into coronal slices, and a maximum-extension ROI is outlined that encloses the VOI. Compensation for background activity and overlapping organs is performed on the basis of total patient thickness in the projection line, and on precalculated organ- background thickness fractions. Results: Method evaluation was performed using data from both experimental measurements and Monte Carlo simulations. The use of an attenuation map derived directly from the CT study was also evaluated. For organ activity quantification, an accuracy of >=10% was obtained. For small-diameter tumors, deviations were larger because of lack of correction for the background-dependent partial-volume effect. Conclusion: Registration of CT and WB scintillation camera images was successfully applied to improve activity quantification by the conjugate view method.

Key Words: image registration • conjugate view • activity quantification • 131I • attenuation correction • scatter correction




This article has been cited by other articles:


Home page
JNMHome page
M. G. Stabin
Uncertainties in Internal Dose Calculations for Radiopharmaceuticals
J. Nucl. Med., May 1, 2008; 49(5): 853 - 860.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
G. Sgouros
Toward Patient-Friendly Cell-Level Dosimetry
J. Nucl. Med., April 1, 2007; 48(4): 496 - 497.
[Full Text] [PDF]


Home page
JNMHome page
M. Ljungberg, K. Sjogreen, X. Liu, E. Frey, Y. Dewaraja, and S.-E. Strand
A 3-Dimensional Absorbed Dose Calculation Method Based on Quantitative SPECT for Radionuclide Therapy: Evaluation for 131I Using Monte Carlo Simulation
J. Nucl. Med., August 1, 2002; 43(8): 1101 - 1109.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.